FORM 6-K

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

dated September 11, 2014

 

Commission File Number 0-51504

 

GENETIC TECHNOLOGIES LIMITED

(Exact Name as Specified in its Charter)

 

N/A

(Translation of Registrant’s Name)

 

60-66 Hanover Street

Fitzroy

Victoria 3065 Australia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x                                           Form 40-F  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes  o                                                                                  No  x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):  Not applicable.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused the Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Date: September 11, 2014
	GENETIC TECHNOLOGIES LIMITED
	By:	/s/ Bronwyn Christie
		Name:	Bronwyn Christie
		Title:	Company Secretary

 

2

 

EXHIBIT INDEX

 

Exhibit		Description of Exhibit
99.1		Voluntary Suspension Request, September 11, 2014

 

3

Exhibit 99.1

 

 

11 September 2014

 

Mr. D. Allen

Adviser, Listing (Perth)

ASX Compliance Pty. Ltd.

Level 8, Exchange Plaza

2 The Esplanade

Perth W.A. 6000

 

Voluntary Suspension Request

 

Genetic Technologies Limited (ASX: GTG, “Company”) requests the securities of the Company be placed in Voluntary Suspension with immediate effect.

 

For the purpose of ASX Listing rule 17.2, and in support of its request, the Company advises that:

 

1.              The voluntary suspension is requested pending an announcement by the Company in relation to the finalisation of a proposed financing;

2.              It requests that the voluntary suspension remain in place until the earlier of the time it makes an announcement to the market about the results of the financing and the commencement of normal trading on Monday, 15 September 2014; and

3.              It is not aware of any reason why the voluntary suspension should not be granted or any other information necessary to inform the market about the voluntary suspension.

 

 

Yours sincerely,
/s/ Alison J. Mew
Alison J. Mew
Chief Executive Officer

 

Genetic Technologies Limited · ABN 17 009 212 328 · Email askus@gtglabs.com · Website www.gtglabs.com · Phone +61 3 8412 7000 · Fax +61 3 8412 7040 Registered Office 60-66 Hanover Street Fitzroy VIC 3065 Australia · Postal Address P.O. Box 115 Fitzroy Victoria 3065 Australia